左芳;潘聪;李雨鹏;

• 1:辽宁省中医药研究院/辽宁中医药大学附属第二医院

摘要(Abstract)：

冠状动脉粥样硬化性心脏病是动脉粥样硬化形成导致心肌缺血缺氧的疾病,最新研究表明表皮生长因子NRG1及其下游受体ERBB组成的NRG1-ERBB通路不仅可以改善心肌供血、促进心肌细胞再生、减轻内质网压力和改善内质网应激、还可以改善缺血再灌注损伤。大量前期动物实验已经证明了在缺血心肌细胞中,NRG1-ERBB通路可以明显改善心肌损伤,对受损的心肌细胞有明显的修复作用。文章将从实验动物研究进展、中医药研究进展、NRG1调节内质网压力和内质网应激、NRG1疗法的临床试验进展四个方面进行梳理,对NRG1-ERBB通路的国内外最新信息进行研究,以为后续实验研究打基础。另外针对NRG1疗法明显的不良反应,适当引入中医药治疗,不仅可以缓解不良反应,也为进一步研究中医中药治疗冠心病提供新思路。

关键词(KeyWords)： 冠心病;NRG1-ERBB;内质网压力;通路

Abstract:

Keywords:

基金项目(Foundation): 辽宁省自然基金面上项目(20170540558);; 辽宁省科技厅项目(20180550494)

作者(Authors): 左芳;潘聪;李雨鹏;

DOI: 10.13729/j.issn.1671-7813.Z20201161

参考文献(References)：

• [1] 刘青.NRG-1/Erbb在防治心梗大鼠心室重构中的作用及机制[D].福州：福建医科大学，2020.
• [2] MENDES-FERREIRA P,MAIA-ROCHA C,ADAO R,et al.Neuregulin-1 improves right ventricular function and attenuates experimental pulmonary arterial hypertension[J].Cardiovasc Res,2016,109(1):44-54.
• [3] CAI M X,SHI X C,CHEN T,et al.Exercise training activates Neuregulin 1/ErbB signaling and promotescardiac repair in a rat myocardial infarction model[J].Life Sciences,2016(149):1-9.
• [4] MANISHA G,HIND L,FIRDOS A,et al.Chronic neuregulin-1p treatment mitigates the progression of postmyocardial infarction heart failure in the setting of type 1 diabetes mellitus by suppressing myocardial apoptosis,fibrosis,and key oxidantproducing enzymes[J].JCard Fail,2017,23(12):887-899.
• [5] LEMMENS K,SEGERS VF,DEMOLDER M,et al.Role of neuregulin-1/ErbB2 signalingin endothelium-cardiomyocyte cross-talk[J].JBiol Chem,2006(281):19469-19477.
• [6] ZHAO Y Y,SAWYERDR,BALIGA RR,et al.Neuregulins promote survival andgrowth of cardiac myocytes.Persistence of ErbB2 and ErbB4 expression in neonatal and adult ventricu-lar myocytes[J].J Biol Chem,1998(273):10261-10269.
• [7] AHMED I,MAHMOUD,CAITLIN C.O’MEARA,et al.Nerves Regulate Cardiomyocyte Proliferation and Heart Regeneration[J].Developmental Cell,2015(34):387-399.
• [8] POLIZZOTTI BD,BALAKRISHNAN GANAPATHY,STUART WALSH,et al.Neuregulin stimulation of cardiomyocyte regeneration in mice and human myocardium reveals a therapeutic window[J].Science Translational Medicine,2015(7):1-14.
• [9] KATHERINE E,YUTZEY.Neuregulin 1 makes heart muscle[J].Nature,2015(520):445-446.
• [10] 聂连桂，刘茂军，陈坚，等.硫化氢通过上调神经调节蛋白1/ErbB2抑制阿霉素诱导的大鼠心肌纤维化[J].中国老年学杂志，2019,39(9):2197-2200.
• [11] DANG R L,GUO Y J,ZHU Y G,et al.Chronic administration of calcitriol enhanced neuregulin-1/ErbB signalingin rat myocardium[J].Pharmazie,2016(71):192-195.
• [12] 李虓，赵晖，史丛宁，等.老年冠心病患者抑郁情绪与血清T3、T4、TSH、rT3及同型半胱氨酸水平的性别异质性研究[J].长春中医药大学学报，2020,36(4):766-769.
• [13] DANG R L,GUO YJ,ZHANG L,et al.Chronic stress and excessive glucocorticoid exposure both lead to alteredNeuregulin-1/ErbB signaling in rat myocardium[J].Steroids,2016(112):47-53.
• [14] 韩凌，张晶晶，秦立.人参皂苷Rb3通过Neuregulin-l/ErbB信号通路对心肌梗死大鼠VE-cadherin,NRG-l,ErbB2,ErbB4表达的影响[J].中国循证心血管医学杂志，2019,11(2):195-199.
• [15] WANG J F,ZHOU J M,WANG Y Y,et al.Qiliqiangxin protects against anoxic injury incardiac microvascular endothelial cells viaNRG-1/ErbB-PI3K/Akt/mTOR pathway[J].J Cell Mol Med,2017,21(9):1905-1914.
• [16] 蒋雷培.NRG1-ERBB信号通路在通心络对急性心肌梗死保护作用中的影响及机制研究[D].北京：北京协和医学院，2006.
• [17] T.MINAMINO,I.KOMURO,M.KITAKAZE.Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease[J].Circ Res,2010,107(9):1071-1082.
• [18] GROENENDYK J,SREENIVASAIAH P K,KIM D H,et al.Biology of endoplasmic reticulum stress in the heart.[J].Circulation Research,2010,107(10):1185-1197.
• [19] LIU X H,ZHANG Z Y,SUN S,et al.Ischemic postconditioning protects myocardium fromischemia/reperfusion injury through attenuating endoplasmic reticulum stress[J].Shock,2008,30(4):422-427.
• [20] K.SHINTANI-ISHIDA,M.NAKAJIMA,K.UEMURA,K,et al.Ischemic preconditioning protects cardiomyocytes against ischemic injury by inducing GRP78[J].Biochem Biophys Res Commun,2006,345(4):1600-1605.
• [21] 赵明，单晓彤，赵亚红，等.阿霉素损伤心肌细胞miR-NA378与calumenin、GRP78、bax及blc-2相关性研究[J].临床心血管病杂志，2016,32(6):603-606.
• [22] 陈春玲，马晓聪，李建橡，等.内质网应激与心血管相关疾病的研究进展[J].广西中医药大学学报，2016,19(4):76-80.
• [23] 邴森，张荣怀，张学军，等.白藜芦醇减轻大鼠心肌缺血再灌注损伤作用的研究[J].山西医科大学学报，2020,51(9):918-925.
• [24] FANG SJUAN,LI PY,WANG CMEI,et al.Inhibition of endoplasmic reticulum stressby neuregulin-1 protects against myocardialischemia/reperfusion injury[J].Peptides,2016(12):9.
• [25] 于雪娇，何金玲，杨博文，等.内质网应激在创伤致大鼠心肌细胞凋亡中的作用[J].中国病理生理杂志，2020,36(7):1237-1242.
• [26] 贺智慧，刘澈，王羽，等.阿霉素诱导的扩张型心肌病大鼠心律失常与内质网应激相关性研究[J].临床心血管病杂志，2017,33(8):798-801.
• [27] GAO R,ZHANG J,CHENG L,et al.A phase II,randomized,double-blind,multicenter,based on standart therapy,placebo-controlled study of th efficacy and safety of recombinant human neuregulin-1 in patients with chronic heart failure[J].J Am Coll Cardiol,2010,55(18):1907-1914.
• [28] LIU X,GU X,LI Z,et al.Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic,dilated,and viral cardiomyopathy[J].J Am Coll Cardiol,2006,48(7):1438-1447.
• [29] COHEN JE,PURCELL BP,MACARTHUR JW JR,et al.A bioengineered hydrogel system enables targeted and sustained intramyocardial delivery of neuregulin,activating the cardiomyocyte cell cycle and enhancing ventricular function in a murine model of ischemic cardiomyopathy[J].Circ Heart Fail,2014,7(4):619-626.
• [30] FORMIGA FR,PELACHO B,GARBAYO E,et al.Controlleddelivery of fibroblast growth factor-1 and neuregulin-1 from biodegradable microparticles promotes cardiac repair in a rat myocardial infarction model through activation of endogenous regeneration[J].Journal of controlled release:official journal of the Controlled Release Society,2014(173):132-139.
• [31] GALINDO CL,KASASBEH E,MURPHY A,et al.Anti-remodeling and antifibrotic effects of the neuregulin-1beta glial growth factor 2 in a large animal model of heart failure[J].Journal of the American Heart Association,2014,3(5):773.
• [32] D'UVA G,AHARONOV A,LAURIOLA M,et al.ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation[J].Nat Cell Biol,2015,17(5):627-638.
• [33] JABBOUR A,HAYWARD CS,KEOGH AM,et al.Parenteral administration of recombinant human neuregulin-1 to patients with stable chronic heart failure produces favourable acute and chronic haemodynamic responses[J].Eur HeartFail,2011,13(1):83-92.
• [34] Parodi EM,Kuhn.Signalling between microvascular endothelium and cardiomyocytes through neuregulin[J].Cardiovascular research,2014,102(2):194-204.
• [35] COTE GM,SAWYER DB,CHABNER BA.ERBB2 inhibition and heart failure.The New England journal of medicine,2012,367(22):2150-2153.
• [36] 张柔，王颖.急性心肌梗死治疗研究进展[J].实用中医内科杂志，2020,34(7):105-108.